A cancer 'vaccine' developed by a Yale University scientist kept people's kidney cancer from recurring for three years, ...
Axel Stuart Merseburger, MD, PhD, explained that with TKIs like axitinib, it is necessary for oncology nurses to spend time ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback